Source: Annual Congress 2006 - Evaluation of drugs for lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. H. Boskabady, P. D. Snashal, S. Adel-Kardan, A. Zarei, S. Tymmori, M. Harati (Mashhad, Islamic Republic Of Iran). Effect of drug delivery and receptor affinity on airway hyperresponsiveness in asthma. Eur Respir J 2006; 28: Suppl. 50, 1250

Member's Comments

No comment yet.

Related content which might interest you: Airway hyperresponsiveness in offspring from mothers with allergic airway inflammation during pregnancy is muscarinic receptor and ADAM33 dependent. Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020 A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Influence of ADRB2 gene polymorphism on cold airway hyperresponsiveness and asthma control depending on inhaled glucocorticoids use Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004 Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006 Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002 Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma Source: Eur Respir J 2002; 19: 997-1002 Year: 2002 Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Role of airway responsivenes in asthma monitoring: new horizons Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Dissociation of the effects of a steroid on inflammation compared to airway hyperresponsiveness (AHR) in a model of asthma in conscious mice Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001 Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma Source: Eur Respir J 2003; 21: 1046-1049 Year: 2003 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020